文献速递生殖医学母胎医学

人类肛门生殖器距离在妊娠早期即已确定

Anogenital distance is determined during early gestation in humans.
PubMed 文献 · Hum Reprod · 2018-01-01

该前瞻性描述性队列研究纳入单中心一年内随机选择的205名新生儿,测量肛门生殖器距离(AGD)并检测脐带血性激素。男性AGD显著长于女性,但校正混杂因素后两性AGD均与出生时性激素水平无关,提示人类AGD在妊娠早期固定且此后不受雄激素影响。

要点

  • 男性新生儿AGD-1和AGD-2均显著长于女性,差异在早至22周胎龄即存在。
  • 脐带血睾酮男性显著高于女性,但17-OHP和雄烯二酮两性无差异。
  • 多因素回归校正后,两性AGD均与任何性激素水平无相关性。

核心结论

  • 人类AGD与动物类似,在妊娠早期(可能为假定的8-14周雄激素编程窗口)即已固定,此后不受雄激素水平影响。
  • AGD可作为人类妊娠早期(可能为8-14周)宫内雄激素作用的生物标志物。
  • 作者认为,人类新生儿和成人生殖健康障碍(如内分泌干扰物相关)的病因应于妊娠早期探索。
  • 作者指出需要进一步更大规模的研究来证实这些发现。

研究设计与样本

  • 前瞻性描述性队列研究,于2015年8月至2016年8月在一家中心随机选取205名新生儿(男117例,女88例)。
  • 胎龄22至41周,出生后24小时内检查(病情严重的早产儿在临床稳定后48-72小时内检查)。
  • 由培训过的护理人员测量AGD-1、AGD-2、阴茎宽度、龟头周长和牵张阴茎长度。
  • 采用液相色谱-串联质谱法检测出生时脐带血血清中的睾酮、17-OHP和雄烯二酮。

主要发现

  • 男性较女性胎龄显著更低(均值±标准差:34.6±4.9 vs 36.1±4.1周,P=0.04)。
  • 男性AGD-1显著长于女性(均值±标准差:21.6±6.0 vs 12.7±3.8 mm,P<0.001)。
  • 男性AGD-2显著长于女性(均值±标准差:41.9±8.7 vs 33.9±7.1 mm,P=0.004)。
  • 脐带血睾酮男性显著高于女性(中位数,四分位距:13.0(7.3,20.5)vs 4.1(2.5,5.9)ng/dl,P<0.001)。
  • 17-OHP(P=0.697)和雄烯二酮(P=0.601)两性间无差异;多因素回归校正混杂因素后,两性AGD均与任何性激素水平无相关性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 未收集生殖器畸形、不孕或激素紊乱的家族史。
  • 未收集父母内分泌干扰化学物暴露或饮食模式数据,这些因素可能影响子代AGD和/或性激素水平。
  • 作者指出需要进一步更大规模的研究来证实这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does cord blood androgen level obtained at birth affect the AGD in human newborns? SUMMARY ANSWER: In human newborns, though males have a significantly longer AGD compared to females (as early as 22 weeks of gestation) the AGD is not affected by androgen levels at birth in both the sexes. WHAT IS KNOWN ALREADY: Animal studies have reported a critical time period in early fetal life, termed the masculinization programming window (MPW) during which AGD is fixed by in utero androgen action and is unaffected by testosterone levels later during gestation. Thus, AGD may serve as a lifelong biomarker of androgen exposure during this window. This MPW is hypothesized to occur in humans at 8-14 weeks of gestation during which AGD is fixed. The effect of androgens (testosterone) on AGD after the MPW in humans is not known. Furthermore, altered AGD has been associated with various human reproductive health disorders in both males and females. STUDY DESIGN, SIZE, DURATION: A prospective descriptive cohort study was performed using data from randomly selected neonates (n = 205) born at a single center over a period of 1 year (August 2015 to August 2016). PARTICIPANTS/MATERIALS, SETTING, METHODS: AGDs in male (n = 117) and female infants (n = 88) together with penile width, glans girth and stretched penile length were measured by trained caregivers. Gestation ranged from 22 to 41 weeks and infants were examined within 24 h of birth (within 48-72 h in very sick preterm infants after clinical stabilization). AGD-1 was measured from the center of the anus to the posterior base of scrotum in males or to the posterior fourchette in females. AGD-2 was measured from the center of the anus to the anterior base of the penis in males or to the clitoris in females. Sex steroid hormones (testosterone, 17-OH progesterone (17-OHP) and androstenedione) were measured in serum prepared from umbilical cord blood samples taken at birth, using liquid chromatography-tandem mass spectrometry. MAIN RESULTS AND THE ROLE OF CHANCE: Males had a significantly lower gestational age (mean ± SD; 34.6 ± 4.9 versus 36.1 ± 4.1 weeks, P = 0.04), and a significantly longer AGD-1 (mean ± SD; 21.6 ± 6.0 versus 12.7 ± 3.8 mm, P < 0.001) and AGD-2 (41.9 ± 8.7 versus 33.9 ± 7.1 mm, P = 0.004) compared to female infants, respectively. The cord serum testosterone levels were significantly higher for male than female infants [median, interquartile range; 13.0 (7.3, 20.5) versus 4.1 (2.5, 5.9), ng/dl, P < 0.001]. There was no difference in levels of 17-OHP (P = 0.697) or androstenedione (P = 0.601) between the two sexes. On multiple regression analysis after adjusting for potential confounders, none of the AGD's in both males and females correlated with any sex steroid hormonal levels. We also provide normative charts for penile length, penile width and glans girth in preterm and term infants. LIMITATIONS, REASONS FOR CAUTION: No data were collected on family history of genital malformation, infertility or hormonal disorders, parental endocrine-disrupting chemical exposure or diet pattern, any of which might have influenced the AGD and/or sex steroid hormone levels in the offspring. WIDER IMPLICATIONS OF THE FINDINGS: Our results suggest that AGD in humans, like animals, is fixed in early gestation (likely during the hypothesized MPW) and is unaffected by androgen levels thereafter. Thus, AGD can serve as a biomarker of in utero androgen action during early gestation (likely 8-14 weeks) in humans. As such, causes of human newborn and adult reproductive health disorders, such as endocrine disruptors, should be explored during early gestation. However, further larger studies are needed to help corroborate these findings. STUDY FUNDING/COMPETING INTERESTS: No specific funding was obtained for this study, and all authors have no conflict of interest to declare.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Jain VG, Goyal V, Chowdhary V, et al. Anogenital distance is determined during early gestation in humans. Hum Reprod. 2018. PMID: 30124868. doi:10.1093/humrep/dey265

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。